# Nuclide record f-molecular-imaging (section). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/fronts/f-molecular-imaging/>
  a schema:DefinedTerm ;
  nuclide:kind "section" ;
  schema:identifier "f-molecular-imaging" ;
  schema:name "Molecular imaging"@en ;
  schema:description "Molecular imaging uses a small radioactive tracer injected into the body and a PET or SPECT camera to show where a specific protein sits on a tumour, so doctors can pick the right treatment and check it is working."@en ;
  schema:url <https://nuclide.cc/fronts/f-molecular-imaging/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pmc.ncbi.nlm.nih.gov/articles/PMC10027805/>, <https://pmc.ncbi.nlm.nih.gov/articles/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC13141699/> ;
  nuclide:related <https://nuclide.cc/fronts/f-radioligand-therapy/>, <https://nuclide.cc/fronts/f-dosimetry/>, <https://nuclide.cc/isotopes/ga-68/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/prostate-bcr/>, <https://nuclide.cc/indications/prostate-high-risk/>, <https://nuclide.cc/indications/neuroendocrine/>, <https://nuclide.cc/indications/rcc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/technologies/sstr-pet/>, <https://nuclide.cc/technologies/fdg-pet/>, <https://nuclide.cc/technologies/fapi-pet/>, <https://nuclide.cc/technologies/pet-ct/>, <https://nuclide.cc/technologies/pet-mri/>, <https://nuclide.cc/technologies/immuno-pet/>, <https://nuclide.cc/technologies/caix-pet/>, <https://nuclide.cc/technologies/her2-pet/>, <https://nuclide.cc/technologies/trop2-pet/>, <https://nuclide.cc/technologies/quantitative-imaging-biomarkers/>, <https://nuclide.cc/technologies/total-body-pet-screening/> ;
  nuclide:drugs <https://nuclide.cc/drugs/ga68-psma-11/>, <https://nuclide.cc/drugs/pylarify/>, <https://nuclide.cc/drugs/flotufolastat/>, <https://nuclide.cc/drugs/psma-1007-f18/>, <https://nuclide.cc/drugs/ga68-dotatate/>, <https://nuclide.cc/drugs/fludeoxyglucose-f18/>, <https://nuclide.cc/drugs/girentuximab-zr89/>, <https://nuclide.cc/drugs/fluoroestradiol-f18/>, <https://nuclide.cc/drugs/illuccix/>, <https://nuclide.cc/drugs/locametz/> ;
  nuclide:companies <https://nuclide.cc/companies/telix/>, <https://nuclide.cc/companies/lantheus/>, <https://nuclide.cc/companies/curium/>, <https://nuclide.cc/companies/blue-earth-diagnostics/>, <https://nuclide.cc/companies/novartis/>, <https://nuclide.cc/companies/ge-healthcare/>, <https://nuclide.cc/companies/siemens-healthineers/>, <https://nuclide.cc/companies/united-imaging/>, <https://nuclide.cc/companies/isotopia/>, <https://nuclide.cc/companies/sofie-biosciences/> ;
  nuclide:terms <https://nuclide.cc/terms/suv/>, <https://nuclide.cc/terms/theranostics/> ;
  nuclide:trials <https://nuclide.cc/trials/propsma/> .